124 related articles for article (PubMed ID: 8960839)
1. Systemic and regional tumour metabolism in a patient with non-islet cell tumour hypoglycaemia: role of increased levels of free insulin-like growth factors.
Møller N; Frystyk J; Skjaerbaek C; Pedersen HB; Christensen C; Schmitz O; Gee A; Gjedde A; Zapf J; Orskov H
Diabetologia; 1996 Dec; 39(12):1534-5. PubMed ID: 8960839
[No Abstract] [Full Text] [Related]
2. Insulin-like growth factor family in malignant haemangiopericytomas: the expression and role of insulin-like growth factor I receptor.
Pavelić K; Pavelić ZP; Cabrijan T; Karner I; Samarzija M; Stambrook PJ
J Pathol; 1999 May; 188(1):69-75. PubMed ID: 10398143
[TBL] [Abstract][Full Text] [Related]
3. [Hepatocellular carcinoma complicated by non-islet cell tumor hypoglycemia].
van Wijngaarden P; Janssen JA; de Man RA
Ned Tijdschr Geneeskd; 2002 May; 146(18):859-62. PubMed ID: 12038225
[TBL] [Abstract][Full Text] [Related]
4. [Hypoglycemia associated with the production of insulin-like growth factor (IGF)-II by a hemangiopericytoma].
Plikat K; Reichle A; Elmlinger MW; Schölmerich J
Dtsch Med Wochenschr; 2003 Feb; 128(6):257-60. PubMed ID: 12571793
[TBL] [Abstract][Full Text] [Related]
5. Non islet cell tumor hypoglycaemia in a metastatic Leydig cell tumor.
Mukherjee S; Diver M; Weston PJ
Acta Oncol; 2005; 44(7):761-3. PubMed ID: 16227169
[TBL] [Abstract][Full Text] [Related]
6. Free insulin-like growth factor (IGF) in disorders of IGF binding protein 3 complex formation.
Daughaday WH
J Clin Endocrinol Metab; 2004 Jan; 89(1):3-5. PubMed ID: 14715816
[No Abstract] [Full Text] [Related]
7. Non-islet cell tumour hypoglycaemia in a patient with a gastrointestinal stromal tumour.
Rikhof B; Van Den Berg G; Van Der Graaf WT
Acta Oncol; 2005; 44(7):764-6. PubMed ID: 16227170
[No Abstract] [Full Text] [Related]
8. The effectiveness of different treatment options for non-islet cell tumour hypoglycaemia.
Teale JD; Wark G
Clin Endocrinol (Oxf); 2004 Apr; 60(4):457-60. PubMed ID: 15049960
[TBL] [Abstract][Full Text] [Related]
9. Temporal changes in insulin-like growth factors I and II and in insulin-like growth factor binding proteins 1, 2, and 3 in human milk.
Milsom SR; Blum WF; Gunn AJ
Horm Res; 2008; 69(5):307-11. PubMed ID: 18259111
[TBL] [Abstract][Full Text] [Related]
10. Levels of insulin-like growth factor after stem cell transplantation.
Munker R; Salat C; Pihusch R; Diem H; Hiller E; Glass J; Kolb HJ; Yu H
Eur J Med Res; 2001 Apr; 6(4):181-4. PubMed ID: 11309231
[TBL] [Abstract][Full Text] [Related]
11. Renal cell carcinoma with non-islet cell tumor hypoglycemia.
Fernando HS; Hawkyard SJ; Poon P; Musa M
Int J Urol; 2006 Jul; 13(7):985-6. PubMed ID: 16882067
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer.
Renehan AG; Jones J; Potten CS; Shalet SM; O'Dwyer ST
Br J Cancer; 2000 Nov; 83(10):1344-50. PubMed ID: 11044360
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of pretreatment plasma levels of insulin-like growth factor (IGF)-1, IGF-2, and IGF binding protein-3 in patients with advanced non-small cell lung cancer.
Han JY; Choi BG; Choi JY; Lee SY; Ju SY
Lung Cancer; 2006 Nov; 54(2):227-34. PubMed ID: 16935391
[TBL] [Abstract][Full Text] [Related]
14. Hypoglycaemia caused by secretion of insulin-like growth factor 2 in a primary renal cell carcinoma.
Berman J; Harland S
Clin Oncol (R Coll Radiol); 2001; 13(5):367-9. PubMed ID: 11716231
[TBL] [Abstract][Full Text] [Related]
15. A case of haemangiopericytoma-associated hypoglycaemia: Beneficial effect of treatment with radiotherapy.
Soran H; Younis N; Joseph F; Hayat Z; Zakhour H; Scott A
Int J Clin Pract; 2006 Oct; 60(10):1319-22. PubMed ID: 16981978
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
[TBL] [Abstract][Full Text] [Related]
17. The insulin-like growth axis in patients with autoimmune thyrotoxicosis: effect of antithyroid drug treatment.
Zimmermann-Belsing T; Juul A; Juul Holst J; Feldt-Rasmussen U
Growth Horm IGF Res; 2004 Jun; 14(3):235-44. PubMed ID: 15125885
[TBL] [Abstract][Full Text] [Related]
18. Inappropriately elevated plasma insulin-like growth factor II in relation to suppressed insulin-like growth factor I in the diagnosis of non-islet cell tumour hypoglycaemia.
Teale JD; Marks V
Clin Endocrinol (Oxf); 1990 Jul; 33(1):87-98. PubMed ID: 2205424
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of insulin-like growth factor-I and -II and insulin-like growth factor binding protein 3 in women with squamous intraepithelial lesions and cervical cancer.
Serrano ML; Romero A; Cendales R; Sánchez-Gómez M; Bravo MM
Biomedica; 2006 Jun; 26(2):258-68. PubMed ID: 16925098
[TBL] [Abstract][Full Text] [Related]
20. [Non-small-cell bronchial carcinoma--prognostic value of IGF protein].
Klein F
Pneumologie; 2007 Oct; 61(10):625. PubMed ID: 17922382
[No Abstract] [Full Text] [Related]
[Next] [New Search]
